The American journal of gastroenterology · 2025
Mildly Elevated Lipase and Subsequent Risk of Acute Pancreatitis and Pancreatic Cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ansari Zaid, Ahmad Akram, Jamal Al-Din Tasneem, Restrepo David, Khan Osama Sherjeel, Channagiri Ritu, Shah Tilak
Аннотация
INTRODUCTION: Long-term risk of acute pancreatitis (AP) and pancreatic cancer (PC) with mildly elevated lipase (MEL) is not well established.
METHODS: Multicenter retrospective cohort study-"MEL" group had MEL without AP; "no MEL" group had abdominal pain but normal lipase, imaging, endoscopy, and labs. Primary outcomes were incidence of AP or PC in MEL vs no MEL after at least 10-year follow-up.
RESULTS: 9,447 patients met inclusion criteria (5,851 MEL, 3,596 no MEL). Logistic regression identified MEL as an independent predictor of AP (2.8% vs 1.2%, odds ratio 2.6, P < 0.001) but not PC (0.4% vs 0.3%, odds ratio 0.7, P 0.38).
DISCUSSION: MEL was associated with increased long-term AP risk.
METHODS: Multicenter retrospective cohort study-"MEL" group had MEL without AP; "no MEL" group had abdominal pain but normal lipase, imaging, endoscopy, and labs. Primary outcomes were incidence of AP or PC in MEL vs no MEL after at least 10-year follow-up.
RESULTS: 9,447 patients met inclusion criteria (5,851 MEL, 3,596 no MEL). Logistic regression identified MEL as an independent predictor of AP (2.8% vs 1.2%, odds ratio 2.6, P < 0.001) but not PC (0.4% vs 0.3%, odds ratio 0.7, P 0.38).
DISCUSSION: MEL was associated with increased long-term AP risk.